NRX PHARMACEUTICALS
NRx Pharmaceuticals is a clinical-stage pharmaceutical company developing therapeutics for the treatment of central nervous system disorders and pulmonary diseases. It addresses life-threatening diseases that often go untreated by researching, developing, and scaling solutions to help people who most desperately need them. The company has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure, and is also developing NRX-100/101 which is the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior. In July 2021, the Government of Israel awarded NRx the exclusive worldwide right to develop and market the BriLifeR COVID vaccine developed by the Israel Institute for Biological Research.
NRX PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Wilmington, Delaware, United States
Country:
United States
Website Url:
http://www.nrxpharma.com
Total Employee:
11+
Status:
Active
Contact:
+1 484.254.6134
Email Addresses:
[email protected]
Total Funding:
80.8 M USD
Technology used in webpage:
SPF Domain Not Resolving IPv6 Microsoft Azure DNS GoDaddy DNS GoDaddy Email Fastly Hosted Fastly Load Balancer SMTP.com
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Curidium Medica
Curidium Medica identifies medicines and companion diagnostics for the treatment of central nervous system disorders.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Interius BioTherapeutics
Interius BioTherapeutics is a biopharmaceutical company developing a paradigm-shifting platform for in vivo cell-specific gene delivery.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
TARIS Biomedical
TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Kinled Holding
Kinled Holding investment in Series C - NRx Pharmaceuticals
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.nrxpharma.com Semrush global rank: 2.18 M Semrush visits lastest month: 9.06 K
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NRx Pharmaceuticals"
NRx Pharmaceuticals - We Bring Hope to Life
NRx is developing breakthrough medicines for people with life-threatening depression and PTSD. Our lead candidate, NRX-101, is the first oral medication in FDA trials for suicidal bipolar …See details»
Our Company - NRx Pharmaceuticals
We are NRx – an agile and specialized CNS biopharma company, resolutely focused on meeting very high unmet medical needs for those with severe bipolar depression with suicidality and post-traumatic stress disorder (PTSD).See details»
Leadership Team Archives - NRx Pharmaceuticals
Dr. Javitt has been a founder of seven successful healthcare IT and biopharma startups with public exits. He has additionally led drug-development engagements for Merck, Allergan, …See details»
NRx Pharmaceuticals, Inc. | LinkedIn
NRx Pharmaceuticals, Inc. draws upon decades of collective, scientific, and drug-development experience to address very high unmet needs of patients and bring improved health to patients.See details»
NRx Pharmaceuticals, Inc. (NRXP) - Yahoo Finance
See the company profile for NRx Pharmaceuticals, Inc. (NRXP) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
NRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE …
Feb 26, 2024 · NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system …See details»
NRx Pharmaceuticals
Nov 15, 2024 · https://www.nrxpharma.com. Overview. Location. Table of content . Summary. History. Mission. Vision. Key Team. Recognition and Award. References. Summary. NRX …See details»
NRx Pharmaceuticals, Inc. (NRXP) Company Profile & Overview
Nov 15, 2024 · NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including …See details»
NRx Pharmaceuticals Eyes First Commercial Revenue in …
May 8, 2024 · NRXP is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRXP has partnered with Alvogen...See details»
NRx Pharmaceuticals, Inc. Commences Trading on Nasdaq as …
May 25, 2021 · - NRx is dedicated to its mission of "Bringing Hope to Life" through the development of innovative medicines for life-threatening, unmet medical needs. - NRx to seek …See details»
NRX Pharmaceuticals - Overview, News & Similar companies
Aug 21, 2024 · NRX Pharmaceuticals contact info: Phone number: (484) 254-6134 Website: www.nrxpharma.com What does NRX Pharmaceuticals do? NRx Pharmaceuticals is a clinical …See details»
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 …
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced its financial results for the quarter ended …See details»
NRx Pharmaceuticals Announces Partnership with the Israel …
Jul 12, 2021 · NRx (www.nrxpharma.com) draws upon more than 300 years of collective, scientific and drug-development experience to bring improved health to patients. Its …See details»
NRx Pharmaceuticals, Inc. | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
NRx Pharmaceuticals, Inc. (NRXP) - Stock Analysis
1 day ago · Get a real-time NRx Pharmaceuticals, Inc. (NRXP) stock price quote with breaking news, financials, statistics, charts and more.See details»
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third …
Nov 7, 2024 · NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system …See details»
NRx Pharma - NRx Pharmaceuticals announced it has... - Facebook
Read More - https://ir.nrxpharma.com/2024-11-18-NRx-Pharmaceuticals... Industry veteran with extensive experience in key areas of focus Interim-CFO Richard Narido to focus on HOPE …See details»
NeuroRx Receives FDA Breakthrough Therapy ... - NRx …
Nov 13, 2018 · WILMINGTON, Del.– (BUSINESS WIRE)– NeuroRx, a clinical stage biopharma company focused on the development of Rapid Acting Antidepressants (RAADs) that target …See details»
NRx Pharma - NRx Pharmaceuticals (NASDAQ:NRXP) Announces.
3 days ago · NRx Pharmaceuticals (NASDAQ:NRXP) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials. Read More - …See details»
NRx Pharmaceuticals, Inc. (NRXP) - Yahoo Finance
NRX Pharmaceuticals Inc (NRXP) reports a 74% reduction in net operating losses and outlines strategic plans for future growth and drug approvals.See details»